410 Medical Raises $3.1M in New Financing

lifeflow410 Medical, Inc., a Durham, NC-based medical device company focused on developing innovative technologies for the resuscitation of critically ill patients, raised $3.1m in new financing.

This round was led by the AIM Group, with participation from the North Carolina Venture Capital Multiplier Fund, Kleinheinz Capital, and WakeMed Health & Hospitals, the health system where 410’s LifeFlow® technology was developed.

Led by Kyle Chenet, President and Chief Executive Officer, 410 Medical is a medical device company focused on the development of innovative technologies for the treatment of critically ill patients.
410 Medical and WakeMed have collaborated since the inception of LifeFlow, a device used for emergent fluid resuscitation. The LifeFlow device was originally developed at WakeMed by physician Dr. Mark Piehl in response to an opportunity he saw to improve outcomes for critically ill patients and, in particular, children with sepsis and other forms of shock.
After FDA clearance and initial evaluation in 2017, WakeMed implemented LifeFlow throughout its multi-hospital system. It is used frequently to treat patients with septic shock, trauma and other emergency conditions with dangerously low blood pressure which can lead to organ failure or death if not treated immediately.
LifeFlow is a tool for rapid delivery of a measured fluid bolus that can resolve hypotension and shock and produce a visible patient response in minutes.

FinSMEs

22/08/2018

Join the discussion